CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

Franca M. Spada, Yasuhiko Koezuka, Steven A. Porcelli

Research output: Contribution to journalArticle

384 Citations (Scopus)

Abstract

A conserved subset of mature circulating T cells in humans expresses an invariant Vα24-JαQ T cell receptor (TCR)-α chain rearrangement and several natural killer (NK) locus-encoded C-type lectins. These human T cells appear to be precise homologues of the subset of NK1.1+ TCR-α/β+ T cells, often referred to as NK T cells, which was initially identified in mice. Here we show that human NK T cell clones are strongly and specifically activated by the same synthetic glycolipid antigens as have been shown recently to stimulate murine NK T cells. Responses of human NK T cells to these synthetic glycolipids, consisting of certain α-anomeric sugars conjugated to an acylated phytosphingosine base, required presentation by antigen-presenting cells expressing the major histocompatibility complex class I-like CD1d protein. Presentation of synthetic glycolipid antigens to human NK T cells required internalization of the glycolipids by the antigen-presenting cell and normal endosomal targeting of CD1d. Recognition of these compounds by human NK T cells triggered proliferation, cytokine release, and cytotoxic activity. These results demonstrate a striking parallel in the specificity of NK T cells in humans and mice, thus providing further insight into the potential mechanisms of immune recognition by NK T cells and the immunological function of this unique T cell subset.

Original languageEnglish (US)
Pages (from-to)1529-1534
Number of pages6
JournalJournal of Experimental Medicine
Volume188
Issue number8
DOIs
StatePublished - Oct 19 1998
Externally publishedYes

Fingerprint

Synthetic Vaccines
Natural Killer T-Cells
Glycolipids
phytosphingosine
Antigen-Presenting Cells
T-Cell Antigen Receptor
T-Lymphocytes
C-Type Lectins
T-Lymphocyte Subsets
Major Histocompatibility Complex
Clone Cells
Cell Proliferation
Cytokines

Keywords

  • Antigen presentation
  • CD1
  • Glycolipid
  • Human
  • Natural killer T cell

ASJC Scopus subject areas

  • Immunology

Cite this

CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. / Spada, Franca M.; Koezuka, Yasuhiko; Porcelli, Steven A.

In: Journal of Experimental Medicine, Vol. 188, No. 8, 19.10.1998, p. 1529-1534.

Research output: Contribution to journalArticle

@article{0ee7dcd55c364234b26aeadafe85cc56,
title = "CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells",
abstract = "A conserved subset of mature circulating T cells in humans expresses an invariant Vα24-JαQ T cell receptor (TCR)-α chain rearrangement and several natural killer (NK) locus-encoded C-type lectins. These human T cells appear to be precise homologues of the subset of NK1.1+ TCR-α/β+ T cells, often referred to as NK T cells, which was initially identified in mice. Here we show that human NK T cell clones are strongly and specifically activated by the same synthetic glycolipid antigens as have been shown recently to stimulate murine NK T cells. Responses of human NK T cells to these synthetic glycolipids, consisting of certain α-anomeric sugars conjugated to an acylated phytosphingosine base, required presentation by antigen-presenting cells expressing the major histocompatibility complex class I-like CD1d protein. Presentation of synthetic glycolipid antigens to human NK T cells required internalization of the glycolipids by the antigen-presenting cell and normal endosomal targeting of CD1d. Recognition of these compounds by human NK T cells triggered proliferation, cytokine release, and cytotoxic activity. These results demonstrate a striking parallel in the specificity of NK T cells in humans and mice, thus providing further insight into the potential mechanisms of immune recognition by NK T cells and the immunological function of this unique T cell subset.",
keywords = "Antigen presentation, CD1, Glycolipid, Human, Natural killer T cell",
author = "Spada, {Franca M.} and Yasuhiko Koezuka and Porcelli, {Steven A.}",
year = "1998",
month = "10",
day = "19",
doi = "10.1084/jem.188.8.1529",
language = "English (US)",
volume = "188",
pages = "1529--1534",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "8",

}

TY - JOUR

T1 - CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells

AU - Spada, Franca M.

AU - Koezuka, Yasuhiko

AU - Porcelli, Steven A.

PY - 1998/10/19

Y1 - 1998/10/19

N2 - A conserved subset of mature circulating T cells in humans expresses an invariant Vα24-JαQ T cell receptor (TCR)-α chain rearrangement and several natural killer (NK) locus-encoded C-type lectins. These human T cells appear to be precise homologues of the subset of NK1.1+ TCR-α/β+ T cells, often referred to as NK T cells, which was initially identified in mice. Here we show that human NK T cell clones are strongly and specifically activated by the same synthetic glycolipid antigens as have been shown recently to stimulate murine NK T cells. Responses of human NK T cells to these synthetic glycolipids, consisting of certain α-anomeric sugars conjugated to an acylated phytosphingosine base, required presentation by antigen-presenting cells expressing the major histocompatibility complex class I-like CD1d protein. Presentation of synthetic glycolipid antigens to human NK T cells required internalization of the glycolipids by the antigen-presenting cell and normal endosomal targeting of CD1d. Recognition of these compounds by human NK T cells triggered proliferation, cytokine release, and cytotoxic activity. These results demonstrate a striking parallel in the specificity of NK T cells in humans and mice, thus providing further insight into the potential mechanisms of immune recognition by NK T cells and the immunological function of this unique T cell subset.

AB - A conserved subset of mature circulating T cells in humans expresses an invariant Vα24-JαQ T cell receptor (TCR)-α chain rearrangement and several natural killer (NK) locus-encoded C-type lectins. These human T cells appear to be precise homologues of the subset of NK1.1+ TCR-α/β+ T cells, often referred to as NK T cells, which was initially identified in mice. Here we show that human NK T cell clones are strongly and specifically activated by the same synthetic glycolipid antigens as have been shown recently to stimulate murine NK T cells. Responses of human NK T cells to these synthetic glycolipids, consisting of certain α-anomeric sugars conjugated to an acylated phytosphingosine base, required presentation by antigen-presenting cells expressing the major histocompatibility complex class I-like CD1d protein. Presentation of synthetic glycolipid antigens to human NK T cells required internalization of the glycolipids by the antigen-presenting cell and normal endosomal targeting of CD1d. Recognition of these compounds by human NK T cells triggered proliferation, cytokine release, and cytotoxic activity. These results demonstrate a striking parallel in the specificity of NK T cells in humans and mice, thus providing further insight into the potential mechanisms of immune recognition by NK T cells and the immunological function of this unique T cell subset.

KW - Antigen presentation

KW - CD1

KW - Glycolipid

KW - Human

KW - Natural killer T cell

UR - http://www.scopus.com/inward/record.url?scp=0032547823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032547823&partnerID=8YFLogxK

U2 - 10.1084/jem.188.8.1529

DO - 10.1084/jem.188.8.1529

M3 - Article

C2 - 9782130

AN - SCOPUS:0032547823

VL - 188

SP - 1529

EP - 1534

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 8

ER -